Our company strategically develops its export potential and overseas sales.
Petrovax is one of Russia's largest exporters of pharmaceuticals and vaccines, supplying 12 countries in the EAEU, the Middle East, and the European Union.
The company has significant competitive advantages in the global market: an original portfolio of innovative products, an investing R&D program and state-of-the-art manufacturing facility according to international standards of GMP.
For more than 20 years Petrovax has been successfully operating in the foreign market. The company is among the TOP-5 immunobiological pharmaceutical manufacturers in Russia.
Our partners are renowned international leaders such as Pfizer, Abbott, and Boehringer Ingelheim. Petrovax has been successfully cooperating with them on localizing the manufacturing of high-tech medicines in Russia and transferring of full-cycle technologies. The company's strategy includes entering new markets and expanding its global presence.